PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Cochlear Limited (COH.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000COH5

Sector

Healthcare

Highlights

Market Cap

A$17.19B

EPS (TTM)

A$5.44

PE Ratio

48.30

Total Revenue (TTM)

A$1.53B

Gross Profit (TTM)

A$1.16B

EBITDA (TTM)

A$318.77M

Year Range

A$261.38 - A$347.77

Target Price

A$294.13

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Cochlear Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-15.00%-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
-11.02%
15.99%
COH.AX (Cochlear Limited)
Benchmark (^GSPC)

Returns By Period

Cochlear Limited had a return of -5.47% year-to-date (YTD) and -16.99% in the last 12 months. Over the past 10 years, Cochlear Limited had an annualized return of 13.32%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.


COH.AX

YTD

-5.47%

1M

-9.64%

6M

-10.23%

1Y

-16.99%

5Y*

2.99%

10Y*

13.32%

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of COH.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202510.26%-5.47%
20241.95%15.01%-3.02%-3.68%-0.78%2.97%3.87%-12.94%-5.40%0.40%7.42%-4.72%-1.64%
20234.08%4.60%7.25%4.20%-1.31%-5.89%4.41%13.51%-5.32%-5.67%13.37%9.39%48.33%
2022-10.91%15.76%1.80%2.84%-3.78%-10.88%7.82%0.03%-8.57%2.66%7.18%-4.63%-4.21%
20214.47%7.08%0.33%5.47%2.04%10.85%-2.52%-4.95%-4.92%0.02%-1.20%-0.77%15.66%
20207.27%-13.89%-8.79%-1.57%4.61%-2.11%0.68%1.01%3.04%7.16%3.88%-14.25%-15.05%
201911.44%-11.85%2.52%8.11%6.83%3.35%6.53%-1.07%-3.71%1.63%10.61%-3.96%31.71%
20181.45%5.86%-0.52%6.85%1.08%2.05%1.59%6.12%-6.30%-11.49%-4.67%2.53%2.91%
20172.14%4.30%4.60%3.44%4.80%6.04%-8.11%9.35%2.83%10.50%2.73%-5.25%42.35%
2016-1.89%9.30%0.88%5.60%11.70%0.48%9.47%6.16%0.93%-9.24%-7.24%3.24%30.72%
20156.82%8.94%1.13%-7.62%5.88%-9.49%13.87%-6.40%-1.11%6.57%6.09%1.28%25.76%
2014-2.87%2.35%-0.52%2.96%2.01%3.06%3.16%13.98%-2.48%5.68%-5.32%11.72%37.21%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of COH.AX is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of COH.AX is 1313
Overall Rank
The Sharpe Ratio Rank of COH.AX is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of COH.AX is 1616
Sortino Ratio Rank
The Omega Ratio Rank of COH.AX is 1616
Omega Ratio Rank
The Calmar Ratio Rank of COH.AX is 99
Calmar Ratio Rank
The Martin Ratio Rank of COH.AX is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cochlear Limited (COH.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for COH.AX, currently valued at -0.60, compared to the broader market-2.000.002.004.00-0.601.83
The chart of Sortino ratio for COH.AX, currently valued at -0.63, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.632.47
The chart of Omega ratio for COH.AX, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.33
The chart of Calmar ratio for COH.AX, currently valued at -0.66, compared to the broader market0.002.004.006.00-0.662.76
The chart of Martin ratio for COH.AX, currently valued at -1.40, compared to the broader market-10.000.0010.0020.0030.00-1.4011.27
COH.AX
^GSPC

The current Cochlear Limited Sharpe ratio is -0.60. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Cochlear Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.60
2.07
COH.AX (Cochlear Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Cochlear Limited provided a 1.50% dividend yield over the last twelve months, with an annual payout of A$4.10 per share. The company has been increasing its dividends for 4 consecutive years.


1.00%1.50%2.00%2.50%3.00%A$0.00A$1.00A$2.00A$3.00A$4.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
DividendA$4.10A$4.10A$3.30A$3.00A$2.55A$1.60A$3.30A$3.00A$2.70A$2.30A$1.90A$2.54

Dividend yield

1.50%1.41%1.10%1.47%1.18%0.85%1.47%1.73%1.58%1.88%1.99%3.27%

Monthly Dividends

The table displays the monthly dividend distributions for Cochlear Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025A$0.00A$0.00A$0.00
2024A$0.00A$0.00A$2.00A$0.00A$0.00A$0.00A$0.00A$0.00A$2.10A$0.00A$0.00A$0.00A$4.10
2023A$0.00A$0.00A$1.55A$0.00A$0.00A$0.00A$0.00A$0.00A$1.75A$0.00A$0.00A$0.00A$3.30
2022A$0.00A$0.00A$1.55A$0.00A$0.00A$0.00A$0.00A$0.00A$1.45A$0.00A$0.00A$0.00A$3.00
2021A$0.00A$0.00A$1.15A$0.00A$0.00A$0.00A$0.00A$0.00A$1.40A$0.00A$0.00A$0.00A$2.55
2020A$0.00A$0.00A$1.60A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$1.60
2019A$0.00A$0.00A$1.55A$0.00A$0.00A$0.00A$0.00A$0.00A$1.75A$0.00A$0.00A$0.00A$3.30
2018A$0.00A$0.00A$1.40A$0.00A$0.00A$0.00A$0.00A$0.00A$1.60A$0.00A$0.00A$0.00A$3.00
2017A$0.00A$0.00A$1.30A$0.00A$0.00A$0.00A$0.00A$0.00A$1.40A$0.00A$0.00A$0.00A$2.70
2016A$0.00A$0.00A$1.10A$0.00A$0.00A$0.00A$0.00A$0.00A$1.20A$0.00A$0.00A$0.00A$2.30
2015A$0.00A$0.00A$0.90A$0.00A$0.00A$0.00A$0.00A$0.00A$1.00A$0.00A$0.00A$0.00A$1.90
2014A$1.27A$0.00A$0.00A$0.00A$0.00A$0.00A$0.00A$1.27A$0.00A$0.00A$0.00A$2.54

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%500.0%600.0%1.5%
Cochlear Limited has a dividend yield of 1.50%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%69.1%
Cochlear Limited has a payout ratio of 69.06%, which is quite average when compared to the overall market. This suggests that Cochlear Limited strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-20.69%
-1.55%
COH.AX (Cochlear Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cochlear Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cochlear Limited was 62.08%, occurring on Mar 23, 2004. Recovery took 456 trading sessions.

The current Cochlear Limited drawdown is 20.69%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.08%Nov 9, 2001618Mar 23, 2004456Jan 3, 20061074
-45.19%Apr 11, 2011123Oct 4, 2011321Jan 10, 2013444
-44.3%Oct 1, 2007184Jun 24, 2008447Mar 26, 2010631
-36.63%Feb 20, 202023Mar 23, 2020319Jun 25, 2021342
-33.74%Jan 22, 201391Jun 3, 2013395Dec 19, 2014486

Volatility

Volatility Chart

The current Cochlear Limited volatility is 16.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
16.44%
3.32%
COH.AX (Cochlear Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cochlear Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Cochlear Limited compared to its peers in the Medical Devices industry.


PE Ratio
50.0100.0150.0200.048.3
The chart displays the price to earnings (P/E) ratio for COH.AX in comparison to other companies of the Medical Devices industry. Currently, COH.AX has a PE value of 48.3. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
-60.0-40.0-20.00.020.040.060.080.00.0
The chart displays the price to earnings to growth (PEG) ratio for COH.AX in comparison to other companies of the Medical Devices industry. Currently, COH.AX has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Cochlear Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab